Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes

The clinical utility of estrogens for treating prostate cancer (CaP) was established in the 1940s by Huggins. The classic model of the anti-CaP activity of estrogens postulates an indirect mechanism involving the suppression of androgen production. However, clinical and preclinical studies have show...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Coleman, Ilsa M, Kiefer, Jeffrey A, Brown, Lisha G, Pitts, Tiffany E, Nelson, Peter S, Brubaker, Kristen D, Vessella, Robert L, Corey, Eva
Materialtyp: Artigo
Språk:Inglês
Publicerad: Neoplasia Press Inc. 2006
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1715921/
https://ncbi.nlm.nih.gov/pubmed/17032503
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk